NAMSA and TERUMO Announce Strategic Outsourcing Partnership
TERUMO CORP UNSP/ADR (TRUMY)
NASDAQ:AMEX Investor Relations:
terumo.com/investor/library/index.html
Company Research
Source: Business Wire
NAMSA’s clinical research, testing and consulting services will help accelerate the regulatory approval of TERUMO’s medical device portfolio on a global level. TOLEDO, Ohio & TOKYO--(BUSINESS WIRE)--NAMSA, a world-leading MedTech Contract Research Organization (CRO) offering end-to-end market access services, and TERUMO, a global leader in medical technology, announced that they have entered into a strategic outsourcing partnership aimed at accelerating the regulatory approval and commercialization of Terumo’s product portfolio.This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241015113976/en/Based in Tokyo and operating globally, Terumo provides innovative medical solutions in more than 160 countries and regions. Its extensive business portfolio ranges from vascular intervention and cardio-surgical solutions, blood transfusion and cell therapy technology, to medical products essential for daily clinical practice such as tr
Show less
Read more
Impact Snapshot
Event Time:
TRUMY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TRUMY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TRUMY alerts
High impacting TERUMO CORP UNSP/ADR news events
Weekly update
A roundup of the hottest topics
TRUMY
News
- Patients, Scientists Agree: Automated Red Blood Cell Exchange Enhances Quality of Life in Sickle Cell Disease PatientsPR Newswire
- Terumo Corporation (TRUMF) Q2 2025 Earnings Call Transcript [Seeking Alpha]Seeking Alpha
- Terumo (TRUMY) Is a Great Choice for 'Trend' Investors, Here's Why [Yahoo! Finance]Yahoo! Finance
- Here's Why Momentum in Terumo (TRUMY) Should Keep going [Yahoo! Finance]Yahoo! Finance
- Are You Looking for a Top Momentum Pick? Why Terumo Corp. (TRUMY) is a Great Choice [Yahoo! Finance]Yahoo! Finance